Investors

Investors image

News

Nov.25, 2022 Release
Shionogi Announces Corporate Reorganization and Personnel Reassignment
Nov.24, 2022 Release
Shionogi Files for Approval of S-268019, a COVID-19 Recombinant Protein-based Vaccine, in Japan
Nov.24, 2022 Notice
Presentation Material for Briefing session on COVID-19
Nov.22, 2022 Release
Xocova® (Ensitrelvir Fumaric Acid) Tablets 125mg Approved in Japan for the Treatment of SARS-CoV-2 Infection, under the Emergency Regulatory Approval System
Nov.21, 2022 Release
SHIONOGI Integrated Report 2022 Won Silver Award in the WICI Japan Integrated Report Award 2022
  • Latest IR Information

    ・Financial Results / Supplement

    　- Presentation material

    　- Transcript

    more
  • IR Library

    ・Financial Results / Supplement

    ・Presentation materials

    ・Annual Report / Integrated Report / EHS Report

    ・Corporate Governance Report

    ・Pipeline

    ・Fact Book

    more
  • Management Policy

    ・Philosophy

    ・Business Plan

    ・Corporate Governance

    ・Disclosure Policy

    ・Business Risks

    more
  • Shareholder Information

    ・Information on Shares

    ・General Meeting of Shareholders

    ・Analyst Coverage

    ・Bonds & Ratings

    more
  • Individual Investors

    ・Pharmaceutical Business

    ・Shionogi's Strength

    ・Business Strategy

    ・Business Activities, etc.

     

    more
  • Sustainability

    View the Shionogi's approach to sustainable growth

    more
  • Financial Highlights

    Financial highlights for the last five years

    more
  • IR Calendar

    The schedule and results of IR events in each fiscal year

     

    more